UCHL3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.33209024208736E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.16469944799746E-10 |
Normal-vs-Stage2 |
7.986200E-04 |
Normal-vs-Stage3 |
6.14730488734949E-13 |
Normal-vs-Stage4 |
2.70690025949705E-10 |
Stage1-vs-Stage2 |
5.107600E-01 |
Stage1-vs-Stage3 |
3.457600E-02 |
Stage1-vs-Stage4 |
1.902030E-01 |
Stage2-vs-Stage3 |
8.027900E-02 |
Stage2-vs-Stage4 |
1.675230E-01 |
Stage3-vs-Stage4 |
6.189600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.69864122767649E-12 |
Normal-vs-AfricanAmerican |
2.242300E-04 |
Normal-vs-Asian |
1.000410E-04 |
Caucasian-vs-AfricanAmerican |
7.148800E-01 |
Caucasian-vs-Asian |
8.696100E-02 |
AfricanAmerican-vs-Asian |
3.616500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.06581410364015E-14 |
Normal-vs-Female |
5.99949999680049E-08 |
Male-vs-Female |
6.522200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.212410E-04 |
Normal-vs-Age(41-60Yrs) |
6.35158592388052E-12 |
Normal-vs-Age(61-80Yrs) |
5.38470379396472E-11 |
Normal-vs-Age(81-100Yrs) |
1.209720E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.865600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.087200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.411400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.377400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.640100E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.417410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.041800E-03 |
Normal-vs-Grade 2 |
1.36690003760265E-09 |
Normal-vs-Grade 3 |
7.27207183359724E-12 |
Normal-vs-Grade 4 |
8.24590395964719E-11 |
Grade 1-vs-Grade 2 |
9.580800E-01 |
Grade 1-vs-Grade 3 |
7.399600E-01 |
Grade 1-vs-Grade 4 |
3.954000E-01 |
Grade 2-vs-Grade 3 |
2.755200E-01 |
Grade 2-vs-Grade 4 |
5.616100E-02 |
Grade 3-vs-Grade 4 |
2.452600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.26770047184743E-10 |
Normal-vs-ccB subtype |
8.96449581233583E-12 |
ccA subtype-vs-ccB subtype |
4.743600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.79950507220406E-11 |
Normal-vs-N1 |
1.86932999999279E-05 |
N0-vs-N1 |
1.584370E-01 |
|
|